Novartis (NVS) CAR-T Therapy Kymriah Receives FDA Approval
August 31, 2017 at 15:58 PM EDT
Novartis AG announced that the FDA has approved its breakthrough gene transfer treatment - CAR-T Therapy Kymriah.
Complete coverage of business news in the Twin Cities, Minnesota and elsewhere, including Fortune 500 Minnesota companies: UnitedHealth Group, Target, Best Buy, 3M, CHS, U.S. Bancorp, General Mills, C.H. Robinson, Land O’Lakes, Ecolab, Ameriprise Financial, Xcel Energy, Hormel Foods, Thrivent Financial, Polaris, Securian Financial Group, Fastenal and Patterson Cos.